Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07443839 · ClinicalTrials.gov registry record · NA

Oncology Legal Navigation Study

A NA study of Financial Stress and Oncology Patients, sponsored by Jean Edward.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT07443839 is a NA study of Financial Stress and Oncology Patients that is actively recruiting participants, run by Jean Edward. The registered enrollment target is 60 participants, below the 173-participant average among 6 other Financial Stress trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07443839, a NA study of Financial Stress and Oncology Patients, is actively recruiting participants, sponsored by Jean Edward.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this study is to implement a sustainable oncology legal navigation program that will provide direct legal navigation services to help patients and caregivers overcome legal barriers to care in order to reduce cancer-related financial toxicity (FT) and improve health-related quality of life (QOL) among patients/caregivers.

Interventions

  • OTHER oncology legal navigation services

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-03-24
Est. Completion 2026-12-31
Phase NA

Sponsor

Jean Edward

4 total trials

What the Registry Record Tells You About NCT07443839

The ClinicalTrials.gov registry entry for NCT07443839 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 173-participant average among 6 other Financial Stress trials with a reported enrollment target (65% lower). The listed sponsor is Jean Edward, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Financial Stress appearing as the primary indexed condition, and to 1 intervention - of which oncology legal navigation services is the first listed.

NCT07443839 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT07443839 about?

NCT07443839 is a clinical study titled "Oncology Legal Navigation Study". The overall objective of this study is to implement a sustainable oncology legal navigation program that will provide direct legal navigation services to help patients and caregivers overcome legal barriers to care in order to reduce cancer-related financial toxicity (FT) and improve health-related ...

What is the current status of trial NCT07443839?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-24. Estimated completion is 2026-12-31.

What conditions does trial NCT07443839 study?

This clinical trial studies the following conditions: Financial Stress, Oncology Patients.

What interventions are being tested in trial NCT07443839?

The interventions under investigation include: oncology legal navigation services (OTHER).

Who is sponsoring clinical trial NCT07443839?

This trial is sponsored by Jean Edward, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07443839 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Financial Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.